fulltext.study @t Gmail

Proteolysis and synthetic strategy of human G-CSF in Escherichia coli BL21(DE3)

Paper ID Volume ID Publish Year Pages File Format Full-Text
17535 42676 2009 8 PDF Available
Title
Proteolysis and synthetic strategy of human G-CSF in Escherichia coli BL21(DE3)
Abstract

We report for the first time that the C-terminal region of hG-CSF suffers from proteolytic degradation when human granulocyte colony-stimulating factor (hG-CSF) is directly expressed in Escherichia coli BL21(DE3). It is believed that the rapid proteolysis occurs at the C-terminus of hG-CSF that is very easily exposed to E. coli protease(s) during a short period following protein synthesis and prior to completion of the formation of the inclusion body. The recombinant hG-CSF that is expressed with an N-terminal fusion partner is effectively protected from the proteolysis. It seems that since the N-terminus of hG-CSF is located very close to the C-terminus, the presence of the N-terminal fusion partner masks the C-terminal region of hG-CSF and protects it from proteolytic degradation by E. coli protease(s). Furthermore, the solubility of hG-CSF markedly increased in E. coli cytoplasm when a stress-responsive and aggregation-resistant protein, i.e. aspartate carbamoyl-transferase catalytic chain (PyrB) was used as a novel N-terminal fusion partner proteins.

Keywords
Human granulocyte colony-stimulating factor (hG-CSF); E. coli BL21(DE3); N-terminal fusion partner; C-terminal proteolysis
First Page Preview
Proteolysis and synthetic strategy of human G-CSF in Escherichia coli BL21(DE3)
Publisher
Database: Elsevier - ScienceDirect
Journal: Enzyme and Microbial Technology - Volume 45, Issue 1, 8 July 2009, Pages 7–14
Authors
, , , , , ,
Subjects
Physical Sciences and Engineering Chemical Engineering Bioengineering